Protalix Biotherapeutics, Inc. (PLX)
2.26
+0.07
(+3.20%)
USD |
NYAM |
Apr 08, 09:31
Protalix Biotherapeutics Market Cap : 182.09M for April 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 162.43M |
| Lisata Therapeutics, Inc. | 45.16M |
| InspireMD, Inc. | 66.46M |
| Lifeward Ltd. | 10.03M |
| Denali Therapeutics, Inc. | 3.188B |
Market Cap Related Metrics
| PS Ratio | 3.388 |
| Price to Book Value | 3.741 |
| Price | 2.26 |
| Earnings Yield | -3.77% |